脑干动静脉畸形的血管内治疗
脑干动静脉畸形约占所有颅内动静脉畸形的5%,出血风险高于幕上者,初始及复发出血死亡率高且近乎一致。治疗适用于破裂和有症状的脑干动静脉畸形以及具有高风险血管构筑特征者。显微手术切除和立体定向放射外科在可行时为理想选择,栓塞最常用作手术或放射外科前的辅助治疗,对于供血动脉为1或2条且不供应功能区脑实质的小病灶也可单独栓塞治疗,但单独栓塞的闭塞率和并发症率报道研究较少。
要点
- 脑干动静脉畸形约占颅内动静脉畸形的5%,出血风险高于幕上者。
- 治疗指征包括破裂、有症状及具有高风险血管构筑特征的脑干动静脉畸形。
- 栓塞多作为手术或放射外科的辅助治疗,小病灶可单独栓塞但相关研究较少。
核心结论
- 脑干动静脉畸形治疗适用于破裂和有症状者以及具有高风险血管构筑特征者。
- 显微手术切除和立体定向放射外科在可行时为理想治疗选择。
- 栓塞最常用作手术或放射外科前的辅助治疗。
- 栓塞作为单独治疗用于供血动脉为1或2条且不供应功能区脑实质的小病灶可能有效。
- 关于单独栓塞治疗脑干动静脉畸形的闭塞率和并发症率仅少数研究报道。
研究设计与样本
- 本文为综述,回顾和讨论栓塞作为脑干动静脉畸形单独治疗的可能作用。
主要发现
- 脑干动静脉畸形约占所有颅内动静脉畸形的5%。
- 脑干动静脉畸形出血风险高于幕上动静脉畸形,初始和复发出血死亡率高且近乎一致。
- 术前栓塞有助于显微手术切除并降低术中及术后出血率。
- 放射外科前栓塞有助于缩小病灶体积、使大病灶适合放射外科干预、提高闭塞概率、降低操作出血风险、稳定病灶直至放疗生效以及提供期间症状缓解。
- 关于单独栓塞治疗脑干动静脉畸形的闭塞率和并发症率仅少数研究报道。
临床怎么用
- 治疗适用于破裂和有症状的脑干动静脉畸形以及具有高风险血管构筑特征者。
- 显微手术切除和立体定向放射外科在可行时为理想治疗选择。
- 栓塞最常用作手术或放射外科前的辅助治疗。
- 栓塞作为单独治疗可能有效用于供血动脉为1或2条且不供应功能区脑实质的小病灶。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brainstem arteriovenous malformations (AVMs) represent ∼5% of all intracranial AVMs and carry a higher risk of hemorrhage than their supratentorial counterparts. There is a high and near-uniform mortality with initial and recurrent episodes of hemorrhage. Brainstem AVMs may also present symptomatically with focal neurologic deficits or hydrocephalus. Treatment is indicated for ruptured and symptomatic brainstem AVMs, as well as those possessing high-risk angioarchitectural features. Microsurgical resection and stereotactic radiosurgery are ideal therapeutic options when feasible. Embolization is most commonly used as adjunctive treatment before surgery or stereotactic radiosurgical irradiation. Preoperative embolization facilitates microsurgical resection and reduces intraoperative and postoperative hemorrhage rates. Use of embolization preradiosurgically helps to reduce nidal size, transforming a large lesion to a size amenable to radiosurgical intervention, increasing the probability of obliteration, decreasing procedural hemorrhage risk, stabilizing the lesion until radiotherapeutic effect achieves obliteration, and providing interval symptomatic resolution. Embolization may also be used effectively as stand-alone monotherapy for small lesions with 1 or 2 arterial feeders not supplying eloquent parenchyma. Although an extensive evidence base exists for clinical usefulness of stereotactic radiosurgery as monotherapy or in combination with other therapeutic modalities, only a few studies have reported specifically on obliteration and complication rates with monotherapeutic embolization in the treatment of brainstem AVMs. The potential role of embolization as monotherapy for brainstem AVMs is reviewed and discussed.
引用
- Zaki Ghali G, Zaki Ghali MG, Zaki Ghali E, et al. Endovascular Therapy for Brainstem Arteriovenous Malformations. World Neurosurg. 2018. PMID: 30149173. doi:10.1016/j.wneu.2018.08.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。